tm logo
MIMRELSA
REGISTERED

on 24 May 2024

Last Applicant/ Owned by

PROTAGONIST THERAPEUTICS INC.

Suite 1407707 Gateway BoulevardNewark CA 94560

US

Serial Number

2270592 filed on 26th May 2023

Registration Number

TMA1235340 registered on 24th May 2024

Registration expiry Date

26th May 2033

Correspondent Address

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

MIMRELSA

Trademark usage description

pharmaceuticals; pharmaceuticals for use in the treatment of cancer and blood diseases and disorders. medical research and information services with Read More

Classification Information


Class [005]
Pharmaceuticals; pharmaceuticals for use in the treatment of cancer and blood diseases and disorders.


Classification kind code

12

Class [042]
Medical research and information services with respect to pharmaceuticals, oncology, and blood diseases and disorders.


Classification kind code

12

Mark Details


Serial Number

2270592

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 06th Mar 2024
Advertised
Submitted for opposition 26
on 08th Feb 2024
Approved
Submitted for opposition 27
on 08th Feb 2024
Approval Notice Sent
Submitted for opposition 22
on 02th Feb 2024
Search Recorded
Submitted for opposition 48
on 11th Aug 2023
Agent Changed
Submitted for opposition 257
on 20th Jul 2023
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 19th Jul 2023
Created
Submitted for opposition 31
on 19th Jul 2023
Formalized
Submitted for opposition 30
on 26th May 2023
Filed
Submitted for opposition 228
on 26th May 2023
International Registration